Imaging Biometrics Ltd.
IQAIF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 23.1% | 13.7% | 2.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 99% | 98.1% | 99.7% | 96.7% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -36.4% | -81.8% | -67.2% | -68.5% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -43.6% | -102.4% | -97.5% | -98.2% |
| EPS Diluted | -0.002 | -0.003 | -0.003 | -0.003 |
| % Growth | 44.8% | -17.2% | 3.3% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |